Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 20, Issue 1, pp. 121-131
PubMed
Published By
Print ISSN
Online ISSN
History
- Received June 5, 2020
- Revision received August 24, 2020
- Accepted November 3, 2020
- Published first December 4, 2020.
Article Versions
- Previous version (December 4, 2020 - 07:26).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Julie Preillon1,#,
- Julia Cuende1,#,
- Virginie Rabolli1,#,
- Lucile Garnero1,
- Marjorie Mercier1,
- Noémie Wald1,
- Angela Pappalardo2,
- Sofie Denies1,
- Diane Jamart1,
- Anne-Catherine Michaux1,
- Romain Pirson1,
- Vincent Pitard2,
- Martine Bagot3,
- Shruthi Prasad1,
- Erica Houthuys1,
- Margreet Brouwer1,
- Reece Marillier1,
- Florence Lambolez1,
- Joäo R. Marchante1,
- Florence Nyawouame1,
- Mathew J. Carter4,
- Véronique Baron-Bodo1,
- Anne Marie-Cardine3,
- Mark Cragg4,
- Julie Déchanet-Merville2,5,
- Gregory Driessens1,#,*, and
- Catherine Hoofd1,#
- 1iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts.
- 2ImmunoConcEpT, UMR 5164, Bordeaux University, CNRS, Bordeaux, France.
- 3INSERM U976, Université de Paris, Hôpital Saint Louis, Paris, France.
- 4Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Southampton University Faculty of Medicine, Southampton, United Kingdom.
- 5Team labeled LIGUE 2017.
- ↵*Corresponding Author:
Gregory Driessens, Rue des Frères Wright 29, Gosselies 6041, Belgium. Phone: 327-191-9962; E-mail: gregory.driessens{at}iteostherapeutics.com
↵#J. Preillon, J. Cuende, V. Rabolli, G. Driessens, and C. Hoofd contributed equally to this article.